A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00937352 · TERMINATED
Trial details
- NCT number
- NCT00937352
- Sponsor
- JANSSEN Alzheimer Immunotherapy Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-09-01
- Enrollment
- 896
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.